REGENXBIO, Inc. (RGNX)
8.65
-0.07
(-0.80%)
USD |
NASDAQ |
Mar 06, 16:00
10.15
+1.50
(+17.34%)
After-Hours: 20:00
REGENXBIO SG&A Expense (TTM) : 60.48M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 491.72M |
| AbbVie, Inc. | 14.01B |
| BioMarin Pharmaceutical, Inc. | 1.153B |
| Altimmune, Inc. | 28.10M |
| Omeros Corp. | 44.20M |